Pharma and Biotech IP USA 2020
About This Event
The life sciences are seeing developments in new technologies and undergoing a period of dramatic change and innovation, all of which are challenging traditional IP strategies and business models.
IAM's inaugural Pharma and Biotech IP USA heads to Boston after four successful years in Europe bringing together leading in-house practitioners and expert counsel to explore next-generation strategies for protecting and exploiting cutting-edge innovation.
Companies already confirmed to attend include:
AbbVie
Aerie Pharmaceuticals
Axcella
Bayer
BIO
Boston Scientific
Bristol Myers Squibb
Evelo Biosciences
GlaxoSmithKline
Lonza
Merck
NantWorks
Novo Nordisk
Pfizer
Pieris Pharma
Recursion Pharma
Synlogic
Thermo Fisher Scientific
USPTO
Time: 08:00 to 18:50
Prices:
In-house counsel: USD 395.00,
Law firms: USD 995.00,
IP service providers: USD 1995.00